F9 and hemophilia A: This point is supported by the observation that five clinical trials of AAV-factor IX vectors for the treatment of hemophilia B have been conducted or currently are in progress, while no clinical trials of rAAV-fVIII vectors in persons with hemophilia A have been initiated.